Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy.

Mazur, Courtney M; Castro Andrade, Christian D; Tokavanich, Nicha; Sato, Tadatoshi; Bruce, Michael; Brooks, Daniel J; Bouxsein, Mary L; Wang, Jialiang S; Wein, Marc N

Mazur, Courtney M; Castro Andrade, Christian D; Tokavanich, Nicha; Sato, Tadatoshi; Bruce, Michael; Brooks, Daniel J; Bouxsein, Mary L; Wang, Jialiang S; Wein, Marc N.

Affiliation

Mazur CM; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Castro Andrade CD; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Tokavanich N; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Sato T; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Bruce M; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Brooks DJ; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Bouxsein ML; Center for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Wang JS; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Wein MN; Center for Advanced Orthopedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

iScience ; 25(9): 105019, 2022 Sep 16.

Article in En | MEDLINE | ID: mdl-36105586

Key words

Orthopedics; endocrinology; molecular biology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: IScience Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google